Page last updated: 2024-08-24

triazoles and ly686017

triazoles has been researched along with ly686017 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brandt, JE; Gehlert, DR; George, DT; Geyer, C; Gilman, J; Heilig, M; Herion, D; Hersh, J; Hommer, D; Hunt, SP; Kielbasa, W; Peng, X; Rawlings, R; Tauscher, JT; Thorsell, A1
Miller, G1
Grosshans, M; Kiefer, F; Mutschler, J1
Kuehn, BM1
Gehlert, DR; Iyengar, S; Kielbasa, W; Marek, G; Mozley, D; Peng, X; Tauscher, J; Vandenhende, F1
Gackenheimer, SL; Gehlert, DR1

Trials

2 trial(s) available for triazoles and ly686017

ArticleYear
Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.
    Science (New York, N.Y.), 2008, Mar-14, Volume: 319, Issue:5869

    Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Animals; Behavior, Addictive; Brain; Emotions; Ethanol; Female; Humans; Hydrocortisone; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Middle Aged; Neurokinin-1 Receptor Antagonists; Pyridines; Receptors, Neurokinin-1; Triazoles

2008
Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2010, Volume: 20, Issue:2

    Topics: Adult; Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Dose-Response Relationship, Drug; Gerbillinae; Humans; Male; Neurokinin-1 Receptor Antagonists; Paroxetine; Peptide Fragments; Pyridines; Radioligand Assay; Radionuclide Imaging; Receptors, Neurokinin-1; Stereotyped Behavior; Substance P; Treatment Outcome; Triazoles

2010

Other Studies

4 other study(ies) available for triazoles and ly686017

ArticleYear
Psychopharmacology. Tackling alcoholism with drugs.
    Science (New York, N.Y.), 2008, Apr-11, Volume: 320, Issue:5873

    Topics: Alcohol Deterrents; Alcoholism; Animals; Controlled Clinical Trials as Topic; Emotions; Humans; Neurokinin-1 Receptor Antagonists; Pyridines; Receptors, Corticotropin-Releasing Hormone; Reward; Stress, Psychological; Triazoles

2008
[A new pharmacological treatment option for alcohol dependence discovered in transnational study: neurokinin-1 receptor antagonist as a possible therapy for alcoholism?].
    Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater, 2008, Volume: 22, Issue:4

    Topics: Adult; Alcohol Deterrents; Alcoholism; Animals; Double-Blind Method; Female; Humans; Male; Mice; Mice, Knockout; Middle Aged; Neurokinin-1 Receptor Antagonists; Pyridines; Randomized Controlled Trials as Topic; Receptors, Neurokinin-1; Recurrence; Research; Substance P; Triazoles; Young Adult

2008
Findings on alcohol dependence point to promising avenues for targeted therapies.
    JAMA, 2009, Apr-22, Volume: 301, Issue:16

    Topics: Alcoholism; Animals; Benzazepines; Humans; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Nicotinic Agonists; Pharmacogenetics; Pyridines; Quinoxalines; Receptors, Corticotropin-Releasing Hormone; Receptors, Opioid, mu; Stress, Psychological; Triazoles; Varenicline

2009
In vitro and ex vivo autoradiography of the NK-1 antagonist [³H]-LY686017 in Guinea pig brain.
    Neuropeptides, 2011, Volume: 45, Issue:2

    Topics: Animals; Autoradiography; Binding Sites; Brain; Guinea Pigs; Molecular Structure; Neurokinin-1 Receptor Antagonists; Pyridines; Radionuclide Imaging; Triazoles

2011